Back to search

Post-Transplantation Cyclophosphamide (Cy) Reduces Graft Rejection and Graft-Versus-Host Disease (GVHD) after Non-Myeloablative, Partially HLA-Mismatched (Haploidentical) Bone Marrow Transplantation (BMT).

Ephraim J. Fuchs, Leo Lunzik, Allen Chen, Michele Phelps, Angelita Crawford
DOI: 10.1182/blood.v104.11.437.437
Blood

Data up to Jan 2025

Published2004
Citations9
References0
Fields
MedicineGastroenterologyInternal medicineSurgery

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

Post-Transplantation Cyclophosphamide (Cy) Reduces Graft Rejection and Graft-Versus-Host… (2004) – Blood | Metascience Observatory Explorer